Ginkgetin

CAS No. 481-46-9

Ginkgetin( Ginkgetin )

Catalog No. M18616 CAS No. 481-46-9

Ginkgetin has anti-influenza virus and anti-fungal activities. Ginkgetin has anti-inflammatory activity, can down-regulates COX-2 induction in vivo against skin inflammatory responses.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 108 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ginkgetin
  • Note
    Research use only, not for human use.
  • Brief Description
    Ginkgetin has anti-influenza virus and anti-fungal activities. Ginkgetin has anti-inflammatory activity, can down-regulates COX-2 induction in vivo against skin inflammatory responses.
  • Description
    Ginkgetin has anti-influenza virus and anti-fungal activities. Ginkgetin has anti-inflammatory activity, can down-regulates COX-2 induction in vivo against skin inflammatory responses. Ginkgetin is a good STAT3 inhibitor and may be a useful lead molecule for development of a therapeutic STAT3 inhibitor. Ginkgetin induces apoptosis in PC-3 cells via activation of caspase 3 and inhibition of survival genes as a potent chemotherapeutic agent for prostate cancer treatment. Ginkgetin has neuroprotective activity against neurological injury induced by MPTP occurs via regulating iron homeostasis, it may provide neuroprotective therapy for Parkinson's disease and iron metabolism disorder related diseases.
  • In Vitro
    Ginkgetin (2.5-20 μM; 48 h) inhibits the growth of Daoy and D283 cell lines, and induces G2/M cell cycle arrest in Daoy cells.Ginkgetin (20-40 μM; 24 h) significantly activates the apoptosis of osteosarcoma cells in a concentration-dependent manner.Ginkgetin (10-20 μM; 3-24 h) down-regulated the expression of Wnt target genes without affecting the expression of β-catenin in medulloblastoma cells.Ginkgetin (1-10 μM; 24 or 48 h) significantly inhibits the VEGF-induced endothelial cell proliferation, migration, and wound recovery in a concentration-dependent manner.Ginkgetin (5-10 μM; 48 h) induces autophagy responsible for cell death in A549.Cell Viability Assay Cell Line:Daoy and D283 cell lines Concentration:2.5, 5, 10, 20 μM Incubation Time:48 hours Result:Inhibited the cell growth, with IC50s of 14.65 and 15.81 μM for Daoy and D283 cells, respectively.Apoptosis Analysis Cell Line:Osteosarcoma cells Concentration:20, 30, 40 μM Incubation Time:24 hours Result:Markedly induced the apoptosis of osteosarcoma cells in a concentration-dependent manner.Cell Cycle Analysis Cell Line:Daoy cells Concentration:2.5, 5, 10, 20 μM Incubation Time:24 hours Result:Increased G2/M phase, compared with that of control, indicating a G2/M cell phase arrest.Cell Cycle Analysis Cell Line:Daoy and D283 cell lines Concentration:10, 20 μM Incubation Time:3, 6, 12, 24 hours Result:Attenuated the expression of Wnt target genes, Axin2, cyclin D1 and survivin at 20 μM for 24 h in Daoy cells.Unaffected the level of total β-catenin and diminished the level of β-catenin phosphorylation in a time- and concentration-dependent manner.
  • In Vivo
    Ginkgetin (25-100 mg/kg; i.p. 2 hours after the onset of ischemia) exerts anti-inflammatory effects on cerebral ischemia/reperfusion-induced injury in a rat model via the TLR4/NF-κB signaling pathway.Ginkgetin (30 mg/kg; intragastrically once per day for 42 d) suppresses tumor growth in A549 cells bearing nude mice. Animal Model:Male Sprague-Dawley rats (200-220 g)Dosage:25, 50, 100 mg/kg Administration:I.p. 2 hours after the onset of ischemia Result:Reduced the neurological de?cit score.Suppressed the expression of NF-κB, TLR4 and IκBαin ischemic penumbra cortex, and inhibited the degradation of IκBα.Decreased the expressions of ICAM-1, COX-2, and iNOS.Downregulated downstream in?ammatory factor PGE2 and TNF-α expression.Decreased IL-1β, IL-6, IL-8, and IL-10 protein expression.
  • Synonyms
    Ginkgetin
  • Pathway
    Endocrinology/Hormones
  • Target
    CaMK
  • Recptor
    STAT3
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    481-46-9
  • Formula Weight
    566.51
  • Molecular Formula
    C32H22O10
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 83.3 mg/mL; 147.04 mM
  • SMILES
    COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)OC)O)C4=C(C=C(C5=C4OC(=CC5=O)C6=CC=C(C=C6)O)O)O
  • Chemical Name
    5,7-dihydroxy-8-[5-(5-hydroxy-7-methoxy-4-oxo-4H-1-benzopyran-2-yl)-2-methoxyphenyl]-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • c-Kit-IN-1

    DCC-2618 is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).

  • CAMKK2 inhibitor 4t

    CAMKK2 inhibitor 4t is a potent, selective, orally available, brain-penetrant CAMKK2 inhibitor with pIC50 of 8.5.

  • CaMKII-IN-1

    A potent and highly selective CaMKII inhibitor with IC50 of 63 nM.